Tourmaline Bio logo

Tourmaline Bio Share Price TRML

$47.98

Live

Last updated on

Bell Icon

This instrument is not available for trading on the INDmoney app on 27 Oct 2025

Check the interactive Tourmaline Bio Stock chart to analyse performance

Tourmaline Bio Key Stats

Check Tourmaline Bio key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$47.98
Open
$47.98
Market Capitalization
$1.2B
Today's Volume
$783.7K
Revenue TTM
$0.0
EBITDA
$-102.4M
Earnings Per Share (EPS)
$-3.44
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-29.62%

Analyst Recommendation on Tourmaline Bio Stock

Rating
Trend

Buy

    91%Buy

    8%Hold

    0%Sell

Based on 12 Wall street analysts offering stock ratings for Tourmaline Bio(by analysts ranked 0 to 5 stars)

About Tourmaline Bio

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York.
Organization
Tourmaline Bio
Employees
76
CEO
Dr. Sandeep C. Kulkarni M.D.
Industry
Miscellaneous

Key Management of Tourmaline Bio

NameTitle
Dr. Sandeep C. Kulkarni M.D.
Co-Founder, CEO & Director
Mr. Ryan Robinson CPA
CFO & Treasurer
Mr. W. Bradford Middlekauff J.D.
Chief Business Officer, General Counsel & Corporate Secretary
Dr. Susan Dana Jones Ph.D.
Chief Technology Officer
Ms. Kimberly Piorkowski
Vice President of People, Culture & Compliance
Dr. Kevin B. Johnson M.B.A., Ph.D.
Chief Regulatory Officer
Ms. Dora Rau
Senior VP & Head of Quality
Mr. Gerhard Hagn Pharm.D.
Chief Commercial Officer
Dr. Emil M. deGoma M.D.
Senior Vice President of Medical Research
Dr. Kristine Erickson O.D., Ph.D.
VP & TA Head of Ophthalmology, Medical Research

Important FAQs about investing in TRML Stock from India :

What is Tourmaline Bio share price today?

Tourmaline Bio share price today is $47.98 as on . Tourmaline Bio share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Tourmaline Bio share?

Tourmaline Bio share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Tourmaline Bio stock price today i.e. is trending at $47.98, lower by 0.6% versus the 52 week high.

How to invest in Tourmaline Bio Stock (TRML) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tourmaline Bio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tourmaline Bio Shares that will get you 0.0313 shares as per Tourmaline Bio share price of $47.98 per share as on October 27, 2025 at 12:00 am IST.

What is the minimum amount required to buy Tourmaline Bio Stock (TRML) from India?

Indian investors can start investing in Tourmaline Bio (TRML) shares with as little as ₹95.2475 or $1 (as of July 01, 2026) using the INDmoney app.
For example: If you want to invest $10 or ₹952.48 in Tourmaline Bio stock (as per the Rupee-Dollar exchange rate as on July 01, 2026). Based on Tourmaline Bio share’s latest price of $47.98 as on October 27, 2025 at 12:00 am IST, you will get 0.2084 shares of Tourmaline Bio. Learn more about fractional shares .

What are the returns that Tourmaline Bio has given to Indian investors in the last 5 years?

Tourmaline Bio stock has given 0.0% share price returns and 28.09% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?